Covering many therapeutic areas
However, the company's main activity is the manufacture of medicine. Sanofi's treatments focus on rare diseases, multiple sclerosis, cancer and diabetes, as well as autoimmune, infectious and cardiovascular diseases. Thus, the pharmaceutical sector generates more than 70 percent of the group's total revenues. One of the group's flagship products is Lantus, a long-term insulin, generating around 2.3 billion euros in 2022.Global leader in vaccines
Vaccine sales amounted to 7.2 billion euros in 2022. Sanofi Pasteur, the group's vaccines division, is one of the world's leaders in this field. From its global headquarters in Lyon, Sanofi Pasteur markets billions of doses of vaccines against influenza, polio, pertussis, meningitis, pneumonia, as well as travel vaccines each year. As a result, the group is responsible for annually generating vaccines for 500 million people worldwide. It is, thus, surprising that Sanofi brought an effective COVID-19 vaccine to market only in November 2022.Sanofi's workforce
Around half of the group's nearly 92 thousand employees are active in Europe. Most of the employees work in the pharmaceutical production, while the second largest group of employees works in the company's sales force.
